Rheumatoid arthritis (RA) is a heterogeneous autoimmune inflammatory disorder defined by
the damage to the bone and cartilage in the synovium, which causes joint impairment and …

For more than 70 years, glucocorticoids (GCs) have been a powerful and affordable
treatment option for inflammatory diseases. However, their benefits do not come without a …

Liposomal formulations, as versatile nanocarrier systems suitable for targeted delivery, have
a highly focused role in the therapy development of unmet clinical needs and diagnostic …

Increasing understanding of the pathogenesis of rheumatoid arthritis (RA) has remarkably
promoted the development of effective therapeutic regimens of RA. Nevertheless, the …

Inflammation, a common feature of many diseases, is an essential immune response that
enables survival and maintains tissue homeostasis. However, in some conditions, the …

Research efforts on nanomaterial-based therapies for the treatment of autoimmune diseases
and cancer have spiked and have made rapid progress over the past years. Nanomedicine …

In normal tissues, the expression of folate receptors is low and limited to cells that are
important for embryonic development or for folate reabsorption. However, in several …

Rheumatoid arthritis (RA) is an autoimmune disease with multifactorial etiology and intricate
pathogenesis. In RA, repeated monotherapy is frequently associated with inadequate …

Recent advancements in technology and science thoroughly changed the basic
understanding and treatment approach of rheumatoid arthritis (RA). RA is a chronic …

Introduction Rheumatoid arthritis (RA) is an autoimmune systemic disease in which
inflammatory and immune cells accumulate in inflamed joints. Researchers aimed at the …